| Engineering the ribosomal DNA in a megabase synthetic chromosome W Zhang, G Zhao, Z Luo, Y Lin, L Wang, Y Guo, A Wang, S Jiang, Q Jiang, ... Science 355 (6329), eaaf3981, 2017 | 232 | 2017 |
| A single-chain photoswitchable CRISPR-Cas9 architecture for light-inducible gene editing and transcription XX Zhou, X Zou, HK Chung, Y Gao, Y Liu, LS Qi, MZ Lin ACS chemical biology 13 (2), 443-448, 2018 | 127 | 2018 |
| A compact synthetic pathway rewires cancer signaling to therapeutic effector release HK Chung, X Zou, BT Bajar, VR Brand, Y Huo, JF Alcudia, JE Ferrell Jr, ... Science 364 (6439), eaat6982, 2019 | 38 | 2019 |
| Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases M Westberg, Y Su, X Zou, L Ning, B Hurst, B Tarbet, MZ Lin bioRxiv, 2020.09. 15.275891, 2020 | 17 | 2020 |
| Ultrafast distant wound response is essential for whole-body regeneration Y Fan, C Chai, P Li, X Zou, JE Ferrell, B Wang Cell 186 (17), 3606-3618. e16, 2023 | 8 | 2023 |
| Improving chromosome synthesis with a semiquantitative phenotypic assay and refined assembly strategy Y Lin, X Zou, Y Zheng, Y Cai, J Dai ACS Synthetic Biology 8 (10), 2203-2211, 2019 | 6 | 2019 |
| Ultrafast and long-range coordination of wound responses is essential for whole-body regeneration Y Fan, C Chai, P Li, X Zou, JE Ferrell Jr, B Wang bioRxiv, 2023 | 1 | 2023 |
| Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations M Westberg, Y Su, X Zou, P Huang, A Rustagi, J Garhyan, PB Patel, ... bioRxiv, 2023.07. 19.549739, 2023 | 1 | 2023 |
| An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations M Westberg, Y Su, X Zou, P Huang, A Rustagi, J Garhyan, PB Patel, ... Science translational medicine 16 (738), eadi0979, 2024 | | 2024 |
| Protease Inhibitors for Treatment or Prevention of Coronavirus Disease MZ Lin, X Zou, MW Soerensen, L Ning, Y Su US Patent App. 17/922,555, 2023 | | 2023 |
| Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations (preprint) M Westberg, Y Su, X Zou, P Huang, A Rustagi, J Garhyan, PB Patel, ... | | 2023 |
| Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases (preprint) M Westberg, Y Su, X Zou, B Hurst, B Tarbet, M Lin, C Parizot, D Sauce, ... | | 2020 |
